I Pierian Inc is categorized under Commercial Medical Research in South San Francisco, CA and active since 2014.
I Pierian Inc was established in 2014, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Nancy Stagliano, Chief Executive Officer at the company’s single location by writing to 951 Gateway Boulevard, South San Francisco, California CA 94080 or by phoning (650) 872-4700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | I Pierian Inc |
| Contact Person: | Nancy Stagliano, Chief Executive Officer |
| Address: | 951 Gateway Boulevard, South San Francisco, California 94080 |
| Phone Number: | (650) 872-4700 |
| Website Address: | ipierian.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2014 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
I Pierian Inc was started in 2014 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Nancy Stagliano, Chief Executive Officer for inquiries that concern I Pierian Inc by calling the company number (650) 872-4700, as your correspondence is most welcome. Additionally, the physical location of the single location of I Pierian Inc can be found at the coordinates 37.659941,-122.396448 as well as the street address 951 Gateway Boulevard in South San Francisco, California 94080.
For its online presence, you may visit I Pierian Inc’s website at ipierian.com and engage with its social media outlets through on Twitter and on Facebook.